Overview Money In Money Out People Positions Interview Endorsements
About To fund research with the highest probability of preventing, slowing or reversing alzheimer's disease. ALL overhead expenses are paid by the board of directors, trustees and CORE group of select donors, allowing 100% of general donations to fund our research programs.
Donations are tax-deductible
Financial Snapshot FY ending 2023-12-31 Financial history 16 17 18 19 20 21 22 23
Latest FY2023: $37.7M · Peak FY2022: $40.7M · Avg: $27.1M
Foreign activity (Schedule F) Total spent abroad $3.3M
Foreign employees 0
Foreign offices 0
Foreign partnership interest No
Foreign trust interest No
Region Activity Spent EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM — — MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, — — EAST ASIA AND THE PACIFIC — —
501(h) election This 501(c)(3) has NOT elected 501(h) — lobbying is permitted but limited under the vaguer "no substantial part of activities" test.
Political & Grant Activity
ALZHEIMERS DISEASE RESEARCH FOUNDATION
Address 34 Washington ST STE 230
Wellesley HLS, MA, 02481-190
Governance Voting board members 7
Independent members 6
Conflict-of-interest policy Yes
Whistleblower policy Yes
Doc-retention policy Yes
Audit committee Yes
990 reviewed by board Yes
Compensation practices Severance payments No
Equity-based comp No
Supplemental retirement plan No
Compensation committee Yes
Used comp survey Yes
Board approved comp Yes
Initial contract exception No
Public records
These open in a new tab. AllCiv doesn't host filings directly — these are the authoritative public-record sources.